Surgical Procedures, Operative: News and Research on Liver Transplantation

MeSH tree: E04.936.450.490

GSK buys liver disease drug for up to $2 bn

British pharmaceutical giant GlaxoSmithKline announced Wednesday the acquisition of a drug under development to treat a common form of liver disease, in a deal worth up to $2 billion.

Updated model reduces liver transplant disparities for women

Since the adoption of a new model for assessing the severity of liver disease, women are more likely to be added to the waitlist for a liver transplant, more likely to receive a transplant, and less likely to drop off the ...

page 3 from 7